comparemela.com

Page 8 - Myles Minter News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Axsome Therapeutics (AXSM) Q3 2023 Earnings Call Transcript

Eli Lilly Strikes $250M Deal to Add Gene-Editing Medicines for Cardio Conditions

Eli Lilly is acquiring Beam Therapeutics’ opt-in rights to three Verve Therapeutics gene-editing therapies for cardiovascular conditions. The deal comes four months after the pharmaceutical giant began a partnership on a preclinical Verve gene-editing therapy for a different target.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.